FibroGen (FGEN) Tops Q2 EPS by 31c

FibroGen (NASDAQ: FGEN) reported Q2 EPS of ($0.28), $0.31 better than the analyst estimate of ($0.59). Revenue for the quarter came in at $43.95 million versus the consensus estimate of $27.74 million.

For earnings history and earnings-related data on FibroGen (FGEN) click here.

You May Also Be Interested In

• BofA lists top 5 themes driving next $1tn in incremental semi sales
• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings